Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Position in PTGX — Protagonist Therapeutics, Inc
CIK 2011081
WARSZAWA, R9
Position in PTGX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$60,270,355
+$10,327,160 QoQ
Shares Held
571,825
0.0% QoQ
Ownership
0.884%
of shares outstanding
% of Portfolio
5.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds $286,343,836 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
765,332 | $101,988,142 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
479,080 | $89,722,102 | |
| 3 | CYTK |
Cytokinetics Inc
|
660,310 | $56,251,808 | |
| 4 | QURE |
uniQure N.V.
|
521,677 | $24,028,442 | |
| 5 | NKTR |
Nektar Therapeutics
|
122,767 | $8,570,364 | |
| 6 | JANX |
Janux Therapeutics, Inc.
|
376,496 | $5,782,978 |
All Filings in PTGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,270,355 | 571,825 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $49,943,195 | 571,825 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||